Results 241 to 250 of about 167,518 (291)

A case report on the long‐term use of teduglutide in a pediatric patient with short bowel syndrome

Nutrition in Clinical Practice, EarlyView.
Abstract Short bowel syndrome (SBS) is the leading cause of intestinal failure, frequently necessitating long‐term parenteral nutrition (PN). Teduglutide (TED), a glucagon‐like peptide‐2 analog, has demonstrated efficacy in reducing PN dependence in both adults and children. However, long‐term data in pediatric populations remain limited.
Tsuyoshi Sakurai, Hironori Kudo, Nakamura Megumi, Ryo Ando, Takuro Kazama, Ryuji Okubo, Masatoshi Hashimoto, Ko Minoshima, Motoshi Wada   +8 more
wiley   +1 more source

Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer. [PDF]

Future Oncol
Yoshinami Y, Yamaguchi S, Shoji H, Okita N, Takamaru H, Hirose T, Hirano H, Takashima A, Imazeki H, Yamamoto S, Koyama S, Ishikawa D, Terauchi J, Tanaka K, Ogawa K, Watanabe H, Kato K.   +16 more
europepmc   +1 more source

A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy. [PDF]

Med Sci Monit
Fang J, Fang J.
europepmc   +1 more source

Fecal microbiota transplantation reduces susceptibility to post-antibiotic CLP-induced sepsis by modulating the gut microbiota and its metabolites. [PDF]

BMC Microbiol
Mo C, Shao R, Shi Z, Lou X, Xue J, Ning D, Liu Y, Jiang W, Wei X, Xiao J, Wang F, Chen G.   +11 more
europepmc   +1 more source

Fecal microbiota transplantation in allergic diseases. [PDF]

World J Methodol
Tüsüz Önata E, Özdemir Ö.
europepmc   +1 more source

Route of fecal microbiota transplantation delivery determined the dynamics and predictability of donor microbe colonization. [PDF]

Anim Microbiome
Oladele P, Dong W, Richert BT, Johnson TA.   +3 more
europepmc   +1 more source